Oncotelic Therapeutics Inc, a clinical-stage biopharmaceutical company, is making strides in the health care sector, specifically within the biotechnology industry. The company is dedicated to developing small molecule injectable drugs aimed at treating cancer. Based in South San Francisco, United States, Oncotelic Therapeutics is focused on revolutionizing cancer treatment by introducing innovative therapies designed to meet unmet medical needs.
As of April 26, 2026, Oncotelic Therapeutics Inc’s close price stood at $0.0346. The company’s stock has experienced significant fluctuations over the past year, with a 52-week high of $0.11 recorded on November 6, 2025, and a 52-week low of $0.02 on February 10, 2026. These fluctuations reflect the volatile nature of the biotechnology sector, particularly for companies in the clinical stages of drug development.
The company’s market capitalization is currently valued at $17,767,880 USD, indicating its relatively small size within the industry. This valuation is further underscored by its price-to-earnings ratio of 0.057, which suggests that the company is not yet profitable or is in a phase where earnings are not yet realized.
Oncotelic Therapeutics Inc is listed on the OTC Bulletin Board, a stock exchange that caters to smaller, often more speculative companies. The company’s initial public offering (IPO) took place on August 26, 1993, marking its entry into the public market and providing it with the capital necessary to advance its research and development efforts.
The company’s mission is to address the significant challenges in cancer treatment by developing therapies that can effectively target and treat various forms of the disease. By focusing on small molecule injectable drugs, Oncotelic Therapeutics aims to offer more targeted and potentially less invasive treatment options compared to traditional therapies.
As Oncotelic Therapeutics continues its clinical trials and research, the company remains committed to its goal of bringing innovative cancer treatments to market. The success of its drug development efforts will be crucial in determining its future growth and impact within the biotechnology and health care sectors.
